Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Synthetic Lubricating Base Oil	887.29M	-	-						320.74M	366.57M
Synthetic Lubricating Base Oil Growth	-	-	-						-12.50%	-6.07%
Medical Supplements	336.15M	-	-						182.74M	95.09M
Medical Supplements Growth	-	-	-						92.18%	5.12%
Emulsifier	58.66M	-	-						-	-
Others	14.65M	-	-						39.72M	29.64M
Others Growth	-	-	-						33.99%	-4.37%
Total	1.30B	-	-						543.20M	491.30M
Total Growth	-	-	-						10.56%	-3.99%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Huadong Region	813.72M	-	-						-	-
South China	70.78M	-	-						44.58M	25.74M
South China Growth	-	-	-						73.20%	-9.65%
North-West Region	15.55M	-	-						5.51M	4.79M
North-West Region Growth	-	-	-						15.03%	27.14%
Northeast China	28.90M	-	-						13.86M	13.62M
Northeast China Growth	-	-	-						1.78%	-31.90%
North China	95.77M	-	-						39.60M	23.57M
North China Growth	-	-	-						68.03%	51.51%
Southwest Region	33.54M	-	-						36.05M	68.75M
Southwest Region Growth	-	-	-						-47.57%	-3.14%
Overseas	114.55M	-	-						30.85M	44.13M
Overseas Growth	-	-	-						-30.10%	-22.17%
Central China	114.00M	-	-						67.62M	33.81M
Central China Growth	-	-	-						99.97%	83.86%
Eastern China	-	-	-						305.12M	276.88M
Eastern China Growth	-	-	-						10.20%	-7.03%
Total	1.29B	-	-						543.20M	491.30M
Total Growth	-	-	-						10.56%	-3.99%

Source: S&P Global Market Intelligence.